PD-L1 expression in both tumors is inducible in vitro and in vivo. To investigate the differences between the host immune responses in both tumors, we examined the phenotypes and activation status of tumor infiltrating lymphocytes (TILs). This evidence concerns the gene CD274 and neoplasm.